The REBIRTH trial is hoping to provide the definitive answer as to whether bromocriptine has additional benefits to women in addition to standard medical therapy. UK is one of 50 centers across the country participating in REBIRTH.
The NIDDK award will provide crucial support for a multi-institutional research team to take a new approach to the study of type 2 diabetes and obesity.
Psychology professor Mark Fillmore is serving as the 2024-25 College of Arts and Sciences’ Distinguished Professor and will deliver the Distinguished Professor Lecture next spring.
A groundbreaking lung cancer screening project co-led by UK's Markey Cancer Center and the University of Colorado Cancer Center is set to expand its reach.
UK's Community and Economic Development Initiative of Kentucky is aligning with the UK Land-grant Engagement and other partners to accelerate economic and community development across Kentucky.
